Listen as Ben Jacoby, Regulatory Expert, talks with Adrian Dawkes about the transition to the new regulations in Europe and UK:

• Can existing products continue to be sold?
• What will global manufacturers need to do?
• What is the impact for companion diagnostics being used alongside drugs in clinical trials?
• How is the environment in Great Britain different, and what does this mean for innovators?
• What’s the impact for patients?

A rare opportunity to hear from one of the most experienced regulatory advisors in this important space.